ArticleScientific reports2022
Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease.
Gabriel C Baccam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it